Clinical Trials Directory

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

Mastering Diabetes Study

A Study of Humanized CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory B-cell ALL and B-cell NHL

Pulmonary Health in Children With Down Syndrome

Speech Entrainment for Aphasia Recovery

Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Palmitate Study: A Method Study of Dietary Lipid Oxidation in Toddlers

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure

Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

A Motion Exergaming Approach for Symptom Management: HNC

Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)

Data Collection Study of Patients with Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT with RIC

Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC

Incident Chronic Obstructive pulmoNary dIsease Cohort Study (ICONIC)

DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers

Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Thorcolumbar Kyphosis Patients With GERD

Registry for Chronic Venous Disease Incidence and Natural Course

Moxidectin for LF, Cote d'Ivoire (DOLF)

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Technology-Enhanced Palliative Care for Advanced Cancer Patients

ACDF Using Structural Allograft Vs. Tritanium C

Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care

Determining the Optimal Dose of Reactive Balance Training After Stroke

RCT Implant Based Breast Reconstruction

Study Dynamic Haptic Robotic Trainer (DHRT) and DHRT+ for CVC Insertion Training for Surgical Residents

Cerliponase Alfa Observational Study in the US

The DAPA-MEMRI Trial

The Effect of Virtual Reality Experience on Infusion-related Pain

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study

Long-Term Follow Up Study of Subjects Previously Administered HMI 102

Stereotactic Body Radiation Therapy (SBRT) for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery

Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care

Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3)

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Geriatric Oncology SuPportive Clinic for ELderly

SATURN Transcatheter Mitral Valve Replacement for Functional Mitral Regurgitation

Efficacy of Fecal Microbiota Transplantation (FMT) in Irritable Bowel Syndrome (IBS)

A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes